Medivolve Inc.

MEDVF

MEDVFMedivolve Inc. US flag

Other OTC

0.01

USD

- -

-0.07EPS

-0.10P/E

-NaNMarket Cap

Nov 12Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

Medivolve Inc.

MEDVF

(Other OTC)

Recent

price

0.01

P/E

ratio

-0.1

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 10/12

Stock

S&P500

-36.36

33.65

-98.73

33.66

-92.93

95.84

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	TTM
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.07	1.59	4.49	0.05	0.03	0.03	Revenue per Share
-13.01	-9.16	-7.18	-4.88	-7.48	-7.19	-4.54	-2.48	-0.59	1.39	-0.31	-1.19	-5.66	-0.34	-0.68	-0.61	-0.54	Basic EPS, GAAP
-13.7	-10.21	-11.44	-2.97	-6.93	-5.82	-1.41	-0.37	-0.84	1.52	-0.2	-1.08	-1.71	-0.43	0.22	-0.12	-0.04	Free Cash Flow per Basic Share
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Dividend per Share
-15.83	-16.97	-20.78	-19.24	-33.92	-39.45	-37.46	-39.24	-14.44	1.59	1.77	0.7	-2.07	0.31	-0.36	-0.94	-0.94	Book Value per Share
20.77	41.16	24.52	34.5	12.41	5.2	1.4	-1.1	1.62	2.31	1.99	0.87	-1.91	0.8	-0.04	-0.61	-0.65	Tangible Book Value per Share
- -	- -	- -	- -	- -	- -	- -	- -	1	2	2	2	7	19	27	27	27	Basic Weighted Avg Shares
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11	87	1	1	1	Sales/Revenue/Turnover
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,693.86	-80.79	15.79	-944.4	-491.38	-387.59	Operating Margin (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	5	2	- -	- -	Depreciation Expense
-1	-2	-2	-2	-3	-3	-2	-1	-1	3	-1	-3	-38	-7	-18	-16	-14	Net Income, GAAP
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Effective Tax Rate (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,787.07	-356.96	-7.61	-1,322.72	-2,397.53	-1,572.02	Profit Margin (%)
1	6	3	6	3	1	- -	-1	1	5	4	2	-24	15	-1	-17	-18	Working Capital
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	LT Debt
2	8	7	13	5	2	1	-1	2	5	5	2	-10	18	- -	-16	-17	Total Equity
- -	- -	- -	- -	- -	- -	- -	- -	- -	-108.77	- -	- -	- -	- -	- -	- -	- -	Return on Invested Capital (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	-42.32	- -	- -	- -	- -	- -	- -	- -	Return on Capital (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-18.58	-96.92	- -	- -	- -	- -	- -	Return on Common Equity (%)

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	- -	- -	-50.56%
Net Income, GAAP	90.49%	331.34%	-10.39%
Free Cash Flow	30.03%	89.66%	-151.83%
Total Cash Common Dividend	- -	- -	- -
Total Equity	-666.28%	-1,206.55%	-4,995.77%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Similar Companies: Thyrocare Technologies Limited (THYROCARE.NS)
Precision System Science Co., Ltd. (PCNEF)
Proteome Sciences plc (PRM.L)
Syneos Health, Inc. (SYNH)
Danaher Corporation (DAP.DE)
Medivolve Inc. (MEDV.NE)
Business: Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada.

Company News

globenewswire.com
a month ago
Medivolve Announces Management Changes
globenewswire.com
8 months ago
Medivolve Announces Change of Auditor
proactiveinvestors.com
9 months ago
Medivolve announces telehealth platform development contract; management and director changes
globenewswire.com
9 months ago
Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors
globenewswire.com
a year ago
Medivolve Announces Change of Auditor and Board Changes
globenewswire.com
a year ago
Medivolve Announces Board Changes
proactiveinvestors.com
a year ago
Medivolve establishes a management services organization in Puerto Rico
proactiveinvestors.com
2 years ago
Medivolve closes previously announced secured convertible note financing for aggregate gross proceeds of $1.2M

Year	Q1	Q2	Q3	Q4	FY
2022	17	9	- -	5	1
2023	- -	- -	- -	- -	1
2024	- -	- -	- -	- -	- -

	Sep'23	Dec'23	Mar'24
Total Current Assets	9	1	1
Accounts Receivable, Net	7	- -	- -
Cash, Cash Equivalents & STI	2	1	- -
Inventories	- -	- -	- -
Total Current Liabilities	17	18	19
Payables & Accruals	15	15	16
ST Debt	2	2	2
Deferred Revenue	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	-0.05	-0.22	-0.26	- -	-0.68
2023	-0.11	-0.06	-0.13	- -	-0.61
2024	-0.03	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	- -	- -	- -	- -	- -
2023	- -	- -	- -	- -	- -
2024	- -	- -	- -	- -	- -

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	TTM
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.07	1.59	4.49	0.05	0.03	0.03	Revenue per Share
-13.01	-9.16	-7.18	-4.88	-7.48	-7.19	-4.54	-2.48	-0.59	1.39	-0.31	-1.19	-5.66	-0.34	-0.68	-0.61	-0.54	Basic EPS, GAAP
-13.7	-10.21	-11.44	-2.97	-6.93	-5.82	-1.41	-0.37	-0.84	1.52	-0.2	-1.08	-1.71	-0.43	0.22	-0.12	-0.04	Free Cash Flow per Basic Share
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Dividend per Share
-15.83	-16.97	-20.78	-19.24	-33.92	-39.45	-37.46	-39.24	-14.44	1.59	1.77	0.7	-2.07	0.31	-0.36	-0.94	-0.94	Book Value per Share
20.77	41.16	24.52	34.5	12.41	5.2	1.4	-1.1	1.62	2.31	1.99	0.87	-1.91	0.8	-0.04	-0.61	-0.65	Tangible Book Value per Share
- -	- -	- -	- -	- -	- -	- -	- -	1	2	2	2	7	19	27	27	27	Basic Weighted Avg Shares
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11	87	1	1	1	Sales/Revenue/Turnover
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,693.86	-80.79	15.79	-944.4	-491.38	-387.59	Operating Margin (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	5	2	- -	- -	Depreciation Expense
-1	-2	-2	-2	-3	-3	-2	-1	-1	3	-1	-3	-38	-7	-18	-16	-14	Net Income, GAAP
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Effective Tax Rate (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,787.07	-356.96	-7.61	-1,322.72	-2,397.53	-1,572.02	Profit Margin (%)
1	6	3	6	3	1	- -	-1	1	5	4	2	-24	15	-1	-17	-18	Working Capital
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	LT Debt
2	8	7	13	5	2	1	-1	2	5	5	2	-10	18	- -	-16	-17	Total Equity
- -	- -	- -	- -	- -	- -	- -	- -	- -	-108.77	- -	- -	- -	- -	- -	- -	- -	Return on Invested Capital (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	-42.32	- -	- -	- -	- -	- -	- -	- -	Return on Capital (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-18.58	-96.92	- -	- -	- -	- -	- -	Return on Common Equity (%)

	Sep'23	Dec'23	Mar'24
ST Debt	2	2	2
LT Borrowings	- -	- -	- -
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	27	27	27
Market Capitalization	2	- -	- -

Medivolve Inc.

Growth Rates

(avg. rate of change)

Company News

Growth Rates

(avg. rate of change)

Quarterly Revenue

Year

Working Capital

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year

Capital Structure